World No. 1 tennis participant Novak Djokovic, who was deported from Australia over vaccine rules, has invested in a Danish biotech agency which is aiming to develop a medical remedy to counter Covid-19. Novak Djokovic was deported from Australia over failure to adjust to vaccine mandate (Reuters Photo)HIGHLIGHTSDjokovic made the funding in June 2020, in response to the CEOThe Danish biotech agency QuantBioRes is engaged on growing a medical remedy to counter CovidDjokovic was deported from Australia after he did not adjust to vaccine regulationsTennis champion Novak Djokovic has an 80% stake of Danish biotech agency QuantBioRes, which is aiming to develop a medical remedy to counter COVID-19, the corporate’s chief govt instructed Reuters on Wednesday.
CEO Ivan Loncarevic, who described himself as an entrepreneur, mentioned the funding was made in June 2020 however declined to say how a lot it was.QuantBioRes has round 11 researchers working in Denmark, Australia and Slovenia, in response to Loncarevic, who pressured they have been engaged on a remedy, not a vaccine.The firm is growing a peptide, which inhibits the coronavirus from infecting the human cell, expects to launch medical trials in Britain this summer time, he added.A spokesperson for Djokovic didn’t instantly reply to a request for remark.The tennis primary has stoked international debate concerning the rights of people that choose to not get vaccinated after he was deported from Australia on Sunday evening, ruling him out of the Australian Open.Click right here for IndiaToday.in’s full protection of the coronavirus pandemic.
